News
Alar Pharmaceuticals Inc. (Alar, TPEx:6785), a clinical-stage pharmaceutical company dedicated to the development of long-acting injectables to treat CNS disorders, today announced the dosing of ...
Law Offices of Howard G. Smith announces an investigation on behalf of Alarum Technologies Ltd. (“Alarum” or the “Company”) (NASDAQ: ALAR) investors c ...
Contacts The Schall Law Firm Brian Schall, Esq. www.schallfirm.com Office: 310-301-3335 [email protected] ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback